Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Journal of Acquired Immune Deficiency Syndromes (1999)|September 9, 2024
Markers of Maternal Bone and Renal Toxicity Through 50 Weeks Postpartum: IMPAACT 2010 (VESTED) TrialGaerolwe Masheto, Sean S Brummel, Lauren Ziemba, et al.
The Journal of Infectious Diseases|June 15, 2024
Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their InfantsDenise L Jacobson, Krista S Crider, Patricia DeMarrais, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2025
Breast Milk Transfer and Infant Exposures to Dolutegravir, Tenofovir, and Tenofovir Alafenamide: Results from IMPAACT 2010/VESTEDTk Nguyen, Jung-Woo Chae, Lauren Ziemba, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2026
Hypertension in a randomized trial of dolutegravir- versus efavirenz-based antiretroviral therapy in pregnant and postpartum women with HIVRisa Hoffman, Sean Brummel, Mauricio Pinilla, et al.
AIDS (London, England)|March 1, 2024
Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trialSufia Dadabhai, Victoria B Chou, Mauricio Pinilla, et al.
Implementation Science Communications|July 28, 2025
Study design and procedures for a hybrid effectiveness-implementation incomplete stepped-wedge cluster-randomized trial to evaluate a differentiated point-of-care HIV diagnosis and management model for the prevention of vertical transmission of HIV in Malawi: The PAC-Man trial protocolMichael E Herce, Caitlin Cassidy, Alexandra Munson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2024
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and PostpartumRisa M Hoffman, Sean Brummel, Lauren Ziemba, et al.
The Lancet. HIV|May 11, 2023
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trialLameck Chinula, Lauren Ziemba, Sean Brummel, et al.
Lancet (London, England)|April 4, 2021
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trialShahin Lockman, Sean S Brummel, Lauren Ziemba, et al.
BMC Health Services Research|August 19, 2025
Leveraging infant visit PrEP screening INtegration & tasK shifting to improve post-partum HIV prevention in Malawi (LINK): a cluster-randomized trial evaluation of a postpartum HIV prevention package among breastfeeding women in MalawiSarah E Rutstein, Valerie A Lucas, Mina C Hosseinipour, et al.
Pageof 9